Published in J Exp Med on July 15, 2002
Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J Exp Med (2008) 2.28
The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J Clin Invest (2009) 2.02
CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J Exp Med (2003) 1.81
Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J Exp Med (2008) 1.46
Complexity of dendritic cell subsets and their function in the host immune system. Immunology (2011) 1.11
Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Immunotherapy (2009) 1.07
Infected CD8α- dendritic cells are the predominant source of IL-10 during establishment of persistent viral infection. Proc Natl Acad Sci U S A (2012) 1.00
Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells. Eur J Immunol (2010) 0.91
Dendritic cells, T cell tolerance and therapy of adverse immune reactions. Clin Exp Immunol (2003) 0.90
Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases. Crit Rev Immunol (2013) 0.90
T cell dynamics during induction of tolerance and suppression of experimental allergic encephalomyelitis. J Immunol (2011) 0.87
Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells. Am J Pathol (2005) 0.86
Dendritic cells: cellular mediators for immunological tolerance. Clin Dev Immunol (2013) 0.86
Fetal exposure to high-avidity TCR ligand enhances expansion of peripheral T regulatory cells. J Immunol (2008) 0.85
Tolerogenic dendritic cells and their applications in transplantation. Cell Mol Immunol (2014) 0.84
Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE. J Autoimmun (2011) 0.83
Sterile inflammation after permanent distal MCA occlusion in hypertensive rats. J Cereb Blood Flow Metab (2013) 0.83
The absence of lymphoid CD8+ dendritic cell maturation in L-selectin-/- respiratory compartment attenuates antiviral immunity. J Immunol (2008) 0.82
Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage. J Immunol Res (2015) 0.79
Gene therapy in the treatment of intestinal inflammation. Int J Colorectal Dis (2003) 0.79
APCs expressing high levels of programmed death ligand 2 sustain the development of CD4 T cell memory. J Immunol (2010) 0.78
Modulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase. PLoS One (2014) 0.78
Role of plasmacytoid dendritic cells for aberrant class II expression in exocrine glands from estrogen-deficient mice of healthy background. Am J Pathol (2009) 0.78
Regulatory B cells in autoimmune diseases and mucosal immune homeostasis. Autoimmunity (2010) 0.77
Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance. J Immunol (2013) 0.77
Impaired dendritic cell function in a spontaneous autoimmune polyneuropathy. J Immunol (2015) 0.76
Co-administration of CD40 agonistic antibody and antigen fails to overcome the induction of oral tolerance. Immunology (2004) 0.76
Immunogenicity of Isogenic IgG in Aggregates and Immune Complexes. PLoS One (2017) 0.75
In trans T cell tolerance exacerbates experimental allergic encephalomyelitis by interfering with protective antibody responses. J Neuroimmunol (2013) 0.75
Antigen-Specific Immune Modulation Targets mTORC1 Function To Drive Chemokine Receptor-Mediated T Cell Tolerance. J Immunol (2016) 0.75
Live Imaging of Immune Responses in Experimental Models of Multiple Sclerosis. Front Immunol (2016) 0.75
Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation. Front Immunol (2017) 0.75
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 25.63
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
Towards a network theory of the immune system. Ann Immunol (Paris) (1974) 16.43
Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med (1979) 12.22
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 9.77
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med (2001) 9.70
FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell (1994) 7.66
CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med (2000) 7.46
Reciprocal control of T helper cell and dendritic cell differentiation. Science (1999) 7.28
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med (2000) 6.45
Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med (1976) 6.33
CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med (1999) 6.06
The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med (2000) 5.74
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A (1999) 5.66
Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med (2000) 5.62
Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med (1990) 5.35
Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature (1996) 5.25
A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med (2000) 5.11
Fc receptor biology. Annu Rev Immunol (1997) 5.08
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med (2001) 4.78
Induction of tolerance by IL-10-treated dendritic cells. J Immunol (1997) 4.65
The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med (1992) 4.58
CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol (2000) 4.41
Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature (1999) 4.13
A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med (1996) 3.66
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med (1996) 3.30
Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med (1989) 3.16
Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol (1997) 2.89
Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol (1989) 2.70
Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med (2002) 2.37
Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med (1997) 2.33
High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J Exp Med (2000) 2.10
Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med (1992) 2.05
Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol (1993) 2.00
Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science (1993) 1.96
Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells. J Exp Med (1991) 1.82
A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J Immunol (1996) 1.67
Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med (2000) 1.62
Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol (2001) 1.51
Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med (Berl) (1997) 1.41
Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J Immunol (1999) 1.34
Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells. J Exp Med (2001) 1.30
IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur J Immunol (2000) 1.30
Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J Immunol (2001) 1.26
Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. J Exp Med (2000) 1.14
Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med (1995) 1.10
Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing. J Exp Med (1997) 1.07
Efficient loading of identical viral peptide onto class II molecules by antigenized immunoglobulin and influenza virus. J Exp Med (1993) 0.95
Multi-modal antigen specific therapy for autoimmunity. Int Rev Immunol (2001) 0.88
NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunol (2007) 2.92
T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc Natl Acad Sci U S A (2003) 2.34
Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J Exp Med (2008) 2.28
Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Sci Signal (2012) 2.24
The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J Clin Invest (2009) 2.02
Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J Clin Invest (2009) 1.87
CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J Exp Med (2003) 1.81
The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells. Proc Natl Acad Sci U S A (2008) 1.61
IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2. Immunity (2004) 1.61
DC subsets in positive and negative regulation of immunity. Immunol Rev (2010) 1.56
T cell costimulation molecules CD80/86 inhibit osteoclast differentiation by inducing the IDO/tryptophan pathway. Sci Transl Med (2014) 1.56
A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J Immunol (2004) 1.48
Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J Exp Med (2008) 1.46
IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection. J Immunol (2009) 1.35
Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J Immunol (2005) 1.26
A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice. Cancer Res (2010) 1.25
Consensual immunity: success-driven development of T-helper-1 and T-helper-2 responses. Nat Rev Immunol (2005) 1.20
Adenylate cyclases of Trypanosoma brucei inhibit the innate immune response of the host. Science (2012) 1.19
Intrinsic and extrinsic regulation of T lymphocyte quiescence. Leuk Lymphoma (2004) 1.16
FoxP3+RORgammat+ T helper intermediates display suppressive function against autoimmune diabetes. J Immunol (2010) 1.15
Role of CD27/CD70 pathway of activation in immunity and tolerance. J Leukoc Biol (2010) 1.13
African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation. J Immunol (2007) 1.09
TLR4 and Toll-IL-1 receptor domain-containing adapter-inducing IFN-beta, but not MyD88, regulate Escherichia coli-induced dendritic cell maturation and apoptosis in vivo. J Immunol (2005) 1.09
Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens. Diabetes (2008) 1.06
Injection of lipopolysaccharide induces the migration of splenic neutrophils to the T cell area of the white pulp: role of CD14 and CXC chemokines. J Leukoc Biol (2007) 1.04
Role of inflammatory dendritic cells in innate and adaptive immunity. Eur J Immunol (2012) 1.02
Tumor microenvironment and lymphocyte infiltration. Cancer Immunol Immunother (2012) 1.02
PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2. Mol Cell Biol (2013) 0.99
Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice. J Immunol (2002) 0.95
Recombinant immunoglobulin-based epitope delivery: a novel class of autoimmune regulators. Int Rev Immunol (2005) 0.95
Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J Immunol (2008) 0.94
IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance. J Immunol (2005) 0.93
STAT5 is an ambivalent regulator of neutrophil homeostasis. PLoS One (2007) 0.90
Biochemical signaling of PD-1 on T cells and its functional implications. Cancer J (2014) 0.89
Depending on their maturation state, splenic dendritic cells induce the differentiation of CD4(+) T lymphocytes into memory and/or effector cells in vivo. Eur J Immunol (2004) 0.89
Treatment of experimental asthma by decoy-mediated local inhibition of activator protein-1. Am J Respir Crit Care Med (2005) 0.88
Alteration of migration and maturation of dendritic cells and T-cell depletion in the course of experimental Trypanosoma cruzi infection. Lab Invest (2003) 0.88
CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation. Cell Cycle (2006) 0.87
T cell dynamics during induction of tolerance and suppression of experimental allergic encephalomyelitis. J Immunol (2011) 0.87
Bidirectional MHC molecule exchange between migratory and resident dendritic cells. J Leukoc Biol (2007) 0.87
Bone marrow-derived IL-13Rα1-positive thymic progenitors are restricted to the myeloid lineage. J Immunol (2012) 0.86
Fetal exposure to high-avidity TCR ligand enhances expansion of peripheral T regulatory cells. J Immunol (2008) 0.85
Mechanisms underlying antigen-specific tolerance of stable and convertible Th17 cells during suppression of autoimmune diabetes. Diabetes (2012) 0.85
Liver stem/progenitor cells in the canals of Hering: cellular origin of hepatocellular carcinoma with bile duct tumor thrombi? Stem Cell Rev (2010) 0.85
Twisted gastrulation (Tsg) is regulated by Tob and enhances TGF-beta signaling in activated T lymphocytes. Blood (2007) 0.85
Investigation of the miR16-1 (C > T) + 7 Substitution in Seven Different Types of Cancer from Three Ethnic Groups. J Oncol (2009) 0.85
RIAM regulates the cytoskeletal distribution and activation of PLC-gamma1 in T cells. Sci Signal (2009) 0.85
Are dendritic cells central to regulatory T cell function? Immunol Lett (2008) 0.82
Antigen presenting cell-derived IL-6 restricts Th2-cell differentiation. Eur J Immunol (2014) 0.81
Developmental expression of IL-12Rβ2 on murine naive neonatal T cells counters the upregulation of IL-13Rα1 on primary Th1 cells and balances immunity in the newborn. J Immunol (2013) 0.81
Variegation and silencing in a lentiviral-based murine transgenic model. Transgenic Res (2009) 0.81
Early effector T cells producing significant IFN-gamma develop into memory. J Immunol (2008) 0.81
The adjuvant OM-174 induces both the migration and maturation of murine dendritic cells in vivo. Vaccine (2003) 0.81
Active Rap1, a small GTPase that induces malignant transformation of hematopoietic progenitors, localizes in the nucleus and regulates protein expression. Leuk Lymphoma (2007) 0.81
Reduced effectiveness of CD4+Foxp3+ regulatory T cells in CD28-deficient NOD.H-2h4 mice leads to increased severity of spontaneous autoimmune thyroiditis. J Immunol (2013) 0.81
Recovery from overt type 1 diabetes ensues when immune tolerance and β-cell formation are coupled with regeneration of endothelial cells in the pancreatic islets. Diabetes (2013) 0.80
In trans T cell tolerance diminishes autoantibody responses and exacerbates experimental allergic encephalomyelitis. J Immunol (2008) 0.80
Overcoming dendritic cell tardiness to triumph over IL-13 receptor: a strategy for the development of effective pediatric vaccines. Discov Med (2010) 0.79
Role of dendritic cells in the regulation of antitumor immunity. Oncoimmunology (2013) 0.79
Break of neonatal Th1 tolerance and exacerbation of experimental allergic encephalomyelitis by interference with B7 costimulation. J Immunol (2003) 0.79
Use of the anti-inflammatory cytokine interleukin-11 to reverse HIV-1gp120 repression of a natural killer cell line. Cell Immunol (2012) 0.78
IL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function. Eur J Immunol (2014) 0.78
Hypoxia in the intestine or solid tumors: a beneficial or deleterious alarm signal? Eur J Immunol (2014) 0.78
APCs expressing high levels of programmed death ligand 2 sustain the development of CD4 T cell memory. J Immunol (2010) 0.78
The heat stable antigen (CD24) is not required for the generation of CD4+ effector and memory T cells by dendritic cells in vivo. Immunol Lett (2004) 0.78
Expression of the Ets transcription factor Erm is regulated through a conventional PKC signaling pathway in the Molt4 lymphoblastic cell line. FEBS Lett (2005) 0.78
Antigen-specific therapy against type 1 diabetes: mechanisms and perspectives. Immunotherapy (2014) 0.77
Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance. J Immunol (2013) 0.77
Immunologic control of tumors by in vivo Fc gamma receptor-targeted antigen loading in conjunction with double-stranded RNA-mediated immune modulation. J Immunol (2006) 0.77
Balancing life and death. Nat Immunol (2004) 0.77
[Association between aldehyde dehydrogenase-2/cytochrome P450 2E1 genetic polymorphism and habit of alcohol drinking and the susceptibility of hepatocellular carcinoma]. Wei Sheng Yan Jiu (2010) 0.77
Cyclophosphamide treatment induces rejection of established P815 mastocytoma by enhancing CD4 priming and intratumoral infiltration of P1E/H-2K(d) -specific CD8+ T cells. Int J Cancer (2013) 0.77
Antigen-free adjuvant assists late effector CD4 T cells to transit to memory in lymphopenic hosts. J Immunol (2013) 0.76
Developmental regulation of the composite CAG promoter activity in the murine T lymphocyte cell lineage. Genesis (2009) 0.76
T-regulatory/T-helper 17: promiscuous signals and fear of commitment. Immunotherapy (2009) 0.75
Early Persistent Blood Eosinophilia in Necrotizing Enterocolitis Is a Predictor of Late Complications. Neonatology (2015) 0.75
High visible photoelectrochemical activity of Ag nanoparticle-sandwiched CdS/Ag/ZnO nanorods. ACS Appl Mater Interfaces (2016) 0.75